Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents (original) (raw)

References

Ball RK, Friis RR, Schönenberger CA, Doppler W, Groner B . 1988 EMBO J. 7: 2089–2095
Bargmann CI, Hung M-C, Weinberg RA . 1986 Cell 45: 649–657
Barrington RE, Subler MA, Rands E, Omer CA, Miller PJ, Hundley JE, Koester SK, Troyer DA, Bearss DJ, Conner MW, Gibbs JB, Hamilton K, Koblan KS, Mosser SD, O'Neill TJ, Schaber MD, Senderak ET, Windle JJ, Oliff A, Kohl NE . 1998 Mol. Cell. Biol. 18: 85–92
Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE . 1988 Cancer Res. 48: 1238–1243
Bradbury JM, Arno J, Edwards PAW . 1993 Oncogene 8: 1551–1558
Bruns CJ, Solorzano CC, Harbison MT, Ozawa S, Tsan R, Fan D, Abbruzzese J, Traxler P, Buchdunger E, Radinsky R, Fidler IJ . 2000 Cancer Res. 60: 2926–2935
Cardiff RD, Wellings SR . 1999 J. Mamm. Gland Biol. Neoplasia 4: 105–122
Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Behm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE . 2000 Oncogene 19: 968–988
Chammas R, Taverna D, Cella N, Santos C, Hynes NE . 1994 J. Cell Sci. 107: 1031–1040
Cobleigh MA, Vogal CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G, Slamon DJ . 1999 J. Clin. Oncol. 17: 2639–2648
Cuny M, Kramer A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S, Theillet C . 2000 Cancer Res. 60: 1077–1083
Danielson KG, Oborn CJ, Durban EM, Butel JS, Medina D . 1984 Proc. Natl. Acad. Sci. USA 81: 3756–3760
DeOme KB, Faulkin LJ, Bern HA, Blair PB . 1959 Cancer Res. 19: 515–520
DiGiovanna MP, Lerman MA, Coffey RJ, Muller WJ, Cardiff RD, Stern DF . 1998 Oncogene 17: 1877–1884
Druker BJ, Lydon NB . 2000 J. Clin. Invest. 105: 3–7
Edwards PAW, Hiby SE, Papkoff J, Bradbury JM . 1992 Oncogene 7: 2041–2051
Fabbro D, Ruetz S, Bodis S, Pruschy M, Csermak K, Man A, Campochiaro P, Wood J, O'Reilly T, Meyer T . 2000 Anti-Cancer Drug Design 15: 17–28
Gianni L . 1997 Sem. Oncology 24: S17-91–S17-96
Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . 1992 Proc. Natl. Acad. Sci. USA 89: 10578–10582
Humphreys RC, Rosen JM . 1997 Cell Growth & Different. 8: 839–849
Hynes NE, Stern DF . 1994 Biochem. Biophys. Acta 1198: 165–184
Hynes NE, Taverna D, Harwerth I-M, Ciardiello F, Salomon DS, Yamamoto T, Groner B . 1990 Mol. Cell. Biol. 10: 4027–4034
Li B, Rosen JM, McMenamin-Balano J, Muller WJ, Perkins A . 1997 Mol. Cell. Biol. 17: 3155–3163
Medina D . 1996 J. Mammary Gland Biol. Neopl. 1: 5–19
Merlo GR, Venesio T, Taverna D, Marte BM, Callahan R, Hynes NE . 1994 Oncogene 9: 443–453
Morgenstern JP, Land H . 1990 Nucl. Acids Res. 18: 3587–3596
Muller WJ, Sinn E, Wallace R, Pattengale PK, Leder P . 1988 Cell 54: 105–115
Murphy KL, Rosen JM . 2000 Oncogene 19: 1045–1051
Norgaard P, Law B, Jospeph H, Page DL, Shyr Y, Mays D, Pietenpol JA, Kohl NE, Oliff A, Coffey Jr RJ, Poulsen HS, Moses HL . 1999 Clin. Cancer Res. 5: 35–42
Olayioye MA, Neve RM, Lane HA, Hynes NE . 2000 EMBO J. 19: 3159–3167
Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396
Rees CN, Sinnett D, Lowdell C, English J, Coombes RC . 1996 Eur. J. Cancer 32A: 2354–2356
Schroeder JA, Lee DC . 1998 Cell Growth Differ. 9: 451–464
Seidman AD, Tierstan A, Hudis C, Gollub M, Barrett S, Yao TJ, Lepore J, Gilewski T, Carrie V, Crown J . 1995 J. Clin. Oncol. 13: 2575–2581
Siegel PM, Hardy WR, Muller WJ . 2000 BioEssays 22: 554–563
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL . 1987 Science 235: 177–182
Smith GH . 1996 Br. Cancer Res. Treat. 39: 21–31

Download references